Caitlin Bever has a Ph.D. in Biological Engineering from the Massachusetts Institute of Technology (MIT), along with a Bachelor’s degree (B.Sc.) with Combined Honors in Physics and Astronomy from the University of British Columbia (UBC). Caitlin received a Medtronic Fellowship for her post-graduate work at MIT and the Rudy Haering Medal for outstanding graduating physics student from UBC. Her academic research focused on understanding how to select useful predictions from uncertain mathematical models of biology. Prior to joining IDM, Caitlin worked on a team at Entelos that built a novel model of atherosclerosis in mouse, paired with an analogous model of cardiovascular disease in human, which improved the design of pre-clinical experiments and identified key indicators for translating results from mouse to human. Caitlin was on assignment in Switzerland for a year and a half as a consultant for Entelos, after which she worked with the malaria modeling group at the Swiss Tropical and Public Health Institute. In her role there, she developed new methods for spatial modeling of entomological inoculation rates and co-wrote a WHO report on how country-specific considerations contribute to the impact of malaria vaccines. As a member of IDM’s research team, Caitlin leads the projects on malaria vaccines and human African trypanosomiasis (HAT) with a focus on disease eradication.